Explore 3 Stock Ideas & Industry Insights Download Free Report

mid-cap

One Gold Mining Stock Entered Overbought Zone - BGL

Oct 28, 2024 | Team Kalkine
One Gold Mining Stock Entered Overbought Zone - BGL

  • BGL:ASX
  • Investment Type
    Mid - Cap
  • Risk Level
  • Action
  • Rec. Price (AU$)

Bellevue Gold Ltd (ASX: BGL)  

Bellevue Gold Limited is an Australian gold mining and exploration company primarily focused on the development of its flagship Bellevue Gold Project, located in Western Australia.

Recommendation Rationale - SELL at AUD 1.630 

  • Trading Near the Resistance: BGL’s share price has surpassed its R2 level recommended on 1 October 2024. Therefore, share price can face resistance at the current levels.
  • Overvalued Multiples: On a forward 12-month basis – key trading multiples (EV/Sales, EV/EBITDA, Price/Earnings, and Price/Cash Flow) are higher than the median of Basic Materials’ sector. a
  • Technical Standpoint: With a 14-day RSI of ~74.52, the stock is in the overbought territory. Thus, the stock price might be overbought and could be due for a price correction or consolidation.
  • High All-In-Sustaining Costs (AISC) in the Near Term: The AISC guidance for FY25 is relatively high at AU$1,750-AU$1,850/oz, which could pressure margins, especially if gold prices decline or remain stagnant. High operating costs make the company more vulnerable to gold price fluctuations.

BGL Daily Chart

 

 (Source: REFINITIV; Analysis by Kalkine Group) 

Valuation Methodology: Price/Cash Flow Approach (FY Jun’25E) (Illustrative)

BGL is expected to trade at a slight premium as the Company’s five-year growth plan aims to increase production to 250,000 ounces by FY28, exploration upside, and potential to benefit from rising gold prices. For conducting the valuation, the following peers have been considered: Newmont Corporation (ASX: NEM), Ora Banda Mining Ltd (ASX: OBM), and Ramelius Resources Ltd (ASX: RMS). 

Considering that the stock has surpassed its R2 level, market uncertainties, and risks associated, the share price can witness resistance at the current levels. Hence, a ‘Sell’ recommendation is given on the stock at the current market price of AUD 1.630, as of 28 October 2024, at 2:45 PM AEDT.               

Markets are trading in a highly volatile zone currently due to certain macro-economic issues and geopolitical issues prevailing geopolitical tensions. Therefore, it is prudent to follow a cautious approach while investing.

Note 1: Past performance is neither an indicator nor a guarantee of future performance.

Note 2: The reference date for all price data, currency, technical indicators, support, and resistance levels is 28 October 2024. The reference data in this report has been partly sourced from REFINITIV.

Note 3: Investment decisions should be made depending on an individual's appetite for upside potential, risks, holding duration, and any previous holdings. An 'Exit' from the stock can be considered if the Target Price mentioned as per the Valuation and or the technical levels provided has been achieved and is subject to the factors discussed above. 

Technical Indicators Defined: -

Support: A level at which the stock prices tend to find support if they are falling, and downtrend may take a pause backed by demand or buying interest.

Resistance: A level at which the stock prices tend to find resistance when they are rising, and uptrend may take a pause due to profit booking or selling interest.

Stop-loss: In general, it is a level to protect further losses in case of any unfavourable movement in the stock prices.


Disclaimer-

Disclaimer This report has been issued by Kalkine New Zealand Limited (FSP691351) (NZBN:9429047678101) (“Kalkine”). Kalkine is a Financial Advice Provider (“FAP”) and is authorised by a Class 1 Financial Advice Provider Licence issued by Financial Markets Authority (“FMA”) to provide financial advice. Kalkine provides only general financial advice through its research reports following a person becoming a member. The reports contain buy/sell/hold and other recommendations in relation to equity securities, managed funds and other managed investment schemes and other financial advice products. The recommendations and opinions in this report and on Kalkine website do not take into account any of your investment objectives, financial situation or needs. Before you make a decision about whether to acquire a financial product, you should obtain the Product Disclosure Statement from the product issuer. You should consider the appropriateness of advice taking into account your own objectives, financial situation and needs and seek independent financial advice before making any financial decisions. If you act on the advice in the research reports, you may have to pay fees, expenses or other amounts (but not to Kalkine). Further information about the complaints and dispute resolution process, as well as information about Kalkine’s duties are available on Kalkine’s website. Please read our Financial Advice Provider (FAP) disclosure statement and Complaints Handling Guide, which are available on the website.

Past performance is not a reliable indicator of future performance.